Orchestra BioMed (OBIO) Competitors $4.94 -0.15 (-2.95%) (As of 12/17/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends OBIO vs. OFIX, IRMD, SIBN, SRDX, KIDS, TMCI, CLPT, TCMD, DCTH, and ANGOShould you be buying Orchestra BioMed stock or one of its competitors? The main competitors of Orchestra BioMed include Orthofix Medical (OFIX), Iradimed (IRMD), SI-BONE (SIBN), Surmodics (SRDX), OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), ClearPoint Neuro (CLPT), Tactile Systems Technology (TCMD), Delcath Systems (DCTH), and AngioDynamics (ANGO). These companies are all part of the "surgical & medical instruments" industry. Orchestra BioMed vs. Orthofix Medical Iradimed SI-BONE Surmodics OrthoPediatrics Treace Medical Concepts ClearPoint Neuro Tactile Systems Technology Delcath Systems AngioDynamics Orthofix Medical (NASDAQ:OFIX) and Orchestra BioMed (NASDAQ:OBIO) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, media sentiment, community ranking, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends. Does the media refer more to OFIX or OBIO? In the previous week, Orthofix Medical had 3 more articles in the media than Orchestra BioMed. MarketBeat recorded 3 mentions for Orthofix Medical and 0 mentions for Orchestra BioMed. Orthofix Medical's average media sentiment score of 1.55 beat Orchestra BioMed's score of 0.93 indicating that Orthofix Medical is being referred to more favorably in the media. Company Overall Sentiment Orthofix Medical Very Positive Orchestra BioMed Positive Which has higher valuation and earnings, OFIX or OBIO? Orchestra BioMed has lower revenue, but higher earnings than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than Orchestra BioMed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOrthofix Medical$746.64M0.92-$151.40M-$3.13-5.73Orchestra BioMed$2.65M70.94-$49.12M-$1.61-3.07 Do analysts prefer OFIX or OBIO? Orthofix Medical currently has a consensus price target of $23.00, indicating a potential upside of 28.28%. Orchestra BioMed has a consensus price target of $15.75, indicating a potential upside of 218.83%. Given Orchestra BioMed's stronger consensus rating and higher probable upside, analysts plainly believe Orchestra BioMed is more favorable than Orthofix Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Orthofix Medical 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75Orchestra BioMed 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community prefer OFIX or OBIO? Orthofix Medical received 402 more outperform votes than Orchestra BioMed when rated by MarketBeat users. However, 100.00% of users gave Orchestra BioMed an outperform vote while only 61.92% of users gave Orthofix Medical an outperform vote. CompanyUnderperformOutperformOrthofix MedicalOutperform Votes41361.92% Underperform Votes25438.08% Orchestra BioMedOutperform Votes11100.00% Underperform VotesNo Votes Do institutionals & insiders have more ownership in OFIX or OBIO? 89.8% of Orthofix Medical shares are held by institutional investors. Comparatively, 53.5% of Orchestra BioMed shares are held by institutional investors. 2.6% of Orthofix Medical shares are held by company insiders. Comparatively, 6.7% of Orchestra BioMed shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Is OFIX or OBIO more profitable? Orthofix Medical has a net margin of -15.18% compared to Orchestra BioMed's net margin of -2,179.33%. Orthofix Medical's return on equity of -21.25% beat Orchestra BioMed's return on equity.Company Net Margins Return on Equity Return on Assets Orthofix Medical-15.18% -21.25% -13.29% Orchestra BioMed -2,179.33%-107.04%-70.88% Which has more volatility and risk, OFIX or OBIO? Orthofix Medical has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500. Comparatively, Orchestra BioMed has a beta of 0.44, meaning that its share price is 56% less volatile than the S&P 500. SummaryOrthofix Medical and Orchestra BioMed tied by winning 9 of the 18 factors compared between the two stocks. Ad Jack Carter Trading"X-Ray Vision" could find thousands of hidden market opportunitiesLet me show you how I trade with “X-Ray vision.” You see, most “trend” traders only use one trend filter when looking for an optimal buy signal. And that can be a big mistake because you can’t see if you’re in a “True Trend.” But my newest trading tool is designed to only target the best, most stable stocks… Using 3 trend filters… which are these green, yellow, and red lines.Just tap here to join the presentation. Get Orchestra BioMed News Delivered to You Automatically Sign up to receive the latest news and ratings for OBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OBIO vs. The Competition Export to ExcelMetricOrchestra BioMedSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$187.79M$4.41B$5.17B$9.30BDividend YieldN/A44.87%4.77%4.06%P/E Ratio-3.0725.23132.2217.52Price / Sales70.9446.601,256.58139.03Price / CashN/A44.2040.7837.95Price / Book2.607.254.904.91Net Income-$49.12M$13.83M$118.85M$225.61M7 Day Performance-12.10%-2.75%14.53%-1.46%1 Month Performance-15.41%3.17%17.44%5.38%1 Year Performance-53.75%45.90%35.31%22.72% Orchestra BioMed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OBIOOrchestra BioMed2.0619 of 5 stars$4.94-2.9%$15.75+218.8%-52.3%$187.79M$2.65M-3.0756OFIXOrthofix Medical2.951 of 5 stars$18.01+0.3%$23.00+27.7%+48.6%$688.16M$746.64M0.001,634Short Interest ↓Positive NewsIRMDIradimed4.8041 of 5 stars$53.18+1.0%$60.00+12.8%+16.4%$673.79M$65.56M36.05110Positive NewsSIBNSI-BONE4.4863 of 5 stars$13.77+2.6%$23.00+67.0%-27.5%$577.51M$138.89M-14.59350Positive NewsSRDXSurmodics4.6268 of 5 stars$40.010.0%$50.00+25.0%+6.0%$573.34M$126.08M-49.42376Analyst ForecastNews CoveragePositive NewsKIDSOrthoPediatrics4.111 of 5 stars$22.28+0.7%$40.00+79.5%-28.5%$539.62M$148.73M-17.98200Positive NewsTMCITreace Medical Concepts1.0781 of 5 stars$7.59+1.2%$7.40-2.5%-27.4%$472.86M$187.12M-7.58250Analyst ForecastCLPTClearPoint Neuro0.8787 of 5 stars$16.18+5.5%$11.33-30.0%+159.7%$446.33M$30.43M-22.21110Positive NewsTCMDTactile Systems Technology3.6629 of 5 stars$17.89-0.2%$23.00+28.6%+26.6%$429.36M$274.42M27.57980DCTHDelcath Systems2.5017 of 5 stars$12.22+0.9%$21.50+75.9%+283.1%$390.72M$22.64M-9.6776Gap DownHigh Trading VolumeANGOAngioDynamics4.4053 of 5 stars$9.33+3.7%$12.00+28.6%+24.7%$379.12M$292.73M-1.51748 Related Companies and Tools Related Companies OFIX Competitors IRMD Competitors SIBN Competitors SRDX Competitors KIDS Competitors TMCI Competitors CLPT Competitors TCMD Competitors DCTH Competitors ANGO Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:OBIO) was last updated on 12/17/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orchestra BioMed Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Orchestra BioMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OBIO Stock Alerts